Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important

被引：1
|
作者：
Markopoulos, Christos [1 ]
机构：
[1] Univ Athens, Dept Surg, Sch Med, Athens 11521, Greece
来源：
BREAST CANCER RESEARCH | 2010年 / 12卷 / 04期
关键词：
PREVENTION;
D O I：
10.1186/bcr2609
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Bone mineral density in women with breast cancer
    Celik, O. Karakoyun
    Turan, Y.
    Kocaaga, Z.
    Gurgan, A.
    Duransoy, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women
    不详
    Drugs & Therapy Perspectives, 2009, 25 (10) : 23 - 26
  • [33] TRENDS IN BONE HEALTH ASSESSMENT ACCORDING TO THE GUIDELINES FOR BREAST CANCER PATIENTS RECEIVING ADJUVANT TREATMENT WITH AROMATASE INHIBITORS
    Punda, M.
    Tabain, A.
    Jukic, T.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S463 - S463
  • [34] EFFECT ON BONE MINERAL DENSITY OF ORAL BISPHOSPHONATES IN WOMEN WITH OSTEOPOROSIS AND BREAST CANCER TREATED WITH AROMATASE INHIBITORS: ARE BONE TURNOVER MARKERS USEFUL IN THESE PATIENTS?
    Vazquez, I.
    Casado, E.
    Larrosa, M.
    Dalmau, E.
    Segui, M. A.
    Gratacos, J.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 321 - 321
  • [35] Bone mineral density screening and monitoring in early breast cancer patients treated with aromatase inhibitors
    Gilani, S.
    Ikram, N.
    ANNALS OF ONCOLOGY, 2022, 33 : S227 - S227
  • [36] Genetic determinants of bone mineral density loss in Aromatase inhibitors treatment
    Rodriguez-Sanz, Maria
    Prieto-alhambra, Daniel
    Servitja-Tormo, Sonia
    Torres-Del-Pliego, Elisa
    Mellibovsky, Leonardo
    Garrigos, Laia
    Garcia-Giralt, Natalia
    Diez-Perez, Adolfo
    Tusquets, Ignacio
    Nogues, Xavier
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [37] Managing bone loss in women with early-stage breast cancer receiving aromatase inhibitors
    Brufsky, Adam M.
    CLINICAL BREAST CANCER, 2007, 8 : S22 - S34
  • [38] Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors
    Charlson, John
    Smith, Elizabeth C.
    Smallwood, Alicia J.
    Laud, Purushottam W.
    Neuner, Joan M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (07): : 875 - 880
  • [39] Changes on Bone Mineral Density after Adjuvant Treatment in Women with Non-metastatic Breast Cancer
    Luz-Milva Rodríguez-Rodríguez
    Eva-María Rodríguez-Rodríguez
    Juana-María Oramas-Rodríguez
    Francisco Santolaria-Fernandez
    Marta Llanos
    Josefina Cruz
    Antonio Martínez
    Emilio González-Reimers
    Angeles Gómez
    Norberto Batista
    Breast Cancer Research and Treatment, 2005, 93 : 75 - 83
  • [40] Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer
    Rodríguez-Rodríguez, LM
    Rodríguez-Rodríguez, EM
    Oramas-Rodríguez, JM
    Santolaria-Fernandez, F
    Llanos, M
    Cruz, J
    Martínez, A
    González-Reimers, E
    Gómez, A
    Batista, N
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 93 (01) : 75 - 83
12345